Tourmaline Bio Files Proxy Statement for 2025 Annual Meeting
| Field | Detail |
|---|---|
| Company | Tourmaline Bio, Inc. |
| Form Type | DEF 14A |
| Filed Date | Apr 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, governance
TL;DR
Tourmaline Bio's proxy statement is out for the June 4th meeting - shareholders vote soon.
AI Summary
Tourmaline Bio, Inc. filed its definitive proxy statement on April 21, 2025, for its annual meeting on June 4, 2025. The company, formerly Talaris Therapeutics, Inc., is involved in the biological products sector. The filing details information related to the company's governance and shareholder matters for the fiscal year ending December 31, 2024.
Why It Matters
This filing provides shareholders with crucial information regarding company leadership, voting matters, and executive compensation, enabling informed participation in the company's governance.
Risk Assessment
Risk Level: low — This is a routine proxy filing that does not contain new financial or operational disclosures that would immediately impact risk.
Key Numbers
- 20250604 — Annual Meeting Date (Shareholders will vote on company matters.)
- 20250421 — Filing Date (Date the definitive proxy statement was filed with the SEC.)
Key Players & Entities
- Tourmaline Bio, Inc. (company) — Filer of the proxy statement
- Talaris Therapeutics, Inc. (company) — Former name of Tourmaline Bio, Inc.
- 20250604 (date) — Date of the annual meeting
- 20250421 (date) — Filing date of the proxy statement
- 2024-12-31 (date) — Fiscal year end
FAQ
What is the primary purpose of this DEF 14A filing?
The primary purpose is to provide shareholders with information for the upcoming annual meeting on June 4, 2025, including details on voting matters and company governance.
When is Tourmaline Bio, Inc.'s annual meeting scheduled?
The annual meeting is scheduled for June 4, 2025.
What was Tourmaline Bio, Inc. formerly known as?
Tourmaline Bio, Inc. was formerly known as Talaris Therapeutics, Inc., with a name change occurring on October 7, 2020.
What is the fiscal year end for Tourmaline Bio, Inc. as indicated in the filing?
The fiscal year end for Tourmaline Bio, Inc. is December 31.
What is the SIC code for Tourmaline Bio, Inc.?
The Standard Industrial Classification (SIC) code for Tourmaline Bio, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 21, 2025 regarding Tourmaline Bio, Inc..